Loading...
$2.7M
Awarded Sep 24, 2026
Competition
FULL AND OPEN COMPETITION
Offers
257
Set-Aside
None
Solicitation Type
BASIC RESEARCH
Performance Timeline
Start
Sep 15, 2026
Estimated start: Sep 23, 2027
Contract: 75F40126C00066
UEI
GM1XX56LEP58
Parent Company
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$2,682,546
Base + Exercised Options
$2,682,546
Total Ceiling Value
$6,954,936
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
Description
EO 14398 BAA TARGETED POLYMER-LIPID NANOPARTICLE PLATFORM FOR BIOPROTAC MEDIATED DEGRADATION OF ONCOFUSION PROTEINS IN EWING SARCOMA
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
Congressional District: 03
Awarding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office